SAM
Silvercrest Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-165,856
| Closed | -$4.81M | – | 837 |
|
2025
Q1 | $4.81M | Sell |
165,856
-958
| -0.6% | -$27.8K | 0.03% | 409 |
|
2024
Q4 | $6.19M | Sell |
166,814
-1,658
| -1% | -$61.6K | 0.04% | 378 |
|
2024
Q3 | $8.18M | Sell |
168,472
-1,104
| -0.7% | -$53.6K | 0.06% | 294 |
|
2024
Q2 | $6.78M | Buy |
169,576
+57,148
| +51% | +$2.29M | 0.05% | 346 |
|
2024
Q1 | $4.94M | Buy |
112,428
+29,182
| +35% | +$1.28M | 0.03% | 392 |
|
2023
Q4 | $5.15M | Hold |
83,246
| – | – | 0.04% | 368 |
|
2023
Q3 | $3.83M | Sell |
83,246
-26,401
| -24% | -$1.21M | 0.03% | 402 |
|
2023
Q2 | $6.3M | Sell |
109,647
-45,221
| -29% | -$2.6M | 0.04% | 326 |
|
2023
Q1 | $5.81M | Sell |
154,868
-68,290
| -31% | -$2.56M | 0.04% | 320 |
|
2022
Q4 | $6.25M | Sell |
223,158
-1,998
| -0.9% | -$56K | 0.05% | 299 |
|
2022
Q3 | $6.33M | Sell |
225,156
-6,120
| -3% | -$172K | 0.05% | 286 |
|
2022
Q2 | $8.05M | Sell |
231,276
-10,425
| -4% | -$363K | 0.06% | 262 |
|
2022
Q1 | $8.68M | Sell |
241,701
-127,250
| -34% | -$4.57M | 0.06% | 278 |
|
2021
Q4 | $8.59M | Hold |
368,951
| – | – | 0.05% | 288 |
|
2021
Q3 | $7.01M | Sell |
368,951
-8,504
| -2% | -$162K | 0.05% | 324 |
|
2021
Q2 | $7.61M | Buy |
377,455
+83,873
| +29% | +$1.69M | 0.05% | 315 |
|
2021
Q1 | $5.38M | Sell |
293,582
-39,215
| -12% | -$718K | 0.04% | 368 |
|
2020
Q4 | $6.69M | Buy |
332,797
+51,817
| +18% | +$1.04M | 0.05% | 310 |
|
2020
Q3 | $5.27M | Sell |
280,980
-5,340
| -2% | -$100K | 0.05% | 330 |
|
2020
Q2 | $6.43M | Sell |
286,320
-5,032
| -2% | -$113K | 0.06% | 267 |
|
2020
Q1 | $4.32M | Sell |
291,352
-8,918
| -3% | -$132K | 0.05% | 304 |
|
2019
Q4 | $5.79M | Buy |
300,270
+69,229
| +30% | +$1.34M | 0.04% | 319 |
|
2019
Q3 | $4.58M | Buy |
+231,041
| New | +$4.58M | 0.04% | 350 |
|